Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperammonemia | 2 | 2020 | 76 | 0.870 |
Why?
|
| Genomics | 8 | 2022 | 5720 | 0.830 |
Why?
|
| Incidental Findings | 3 | 2018 | 689 | 0.790 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.740 |
Why?
|
| Genome, Human | 6 | 2021 | 4420 | 0.610 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2018 | 3597 | 0.510 |
Why?
|
| Genetic Testing | 7 | 2021 | 3444 | 0.450 |
Why?
|
| Software | 4 | 2022 | 4443 | 0.360 |
Why?
|
| Computational Biology | 4 | 2022 | 3521 | 0.350 |
Why?
|
| Craniofacial Abnormalities | 2 | 2021 | 315 | 0.310 |
Why?
|
| Leukoencephalopathies | 2 | 2020 | 238 | 0.300 |
Why?
|
| Purpura Fulminans | 1 | 2024 | 22 | 0.240 |
Why?
|
| Growth Disorders | 2 | 2020 | 645 | 0.230 |
Why?
|
| Database Management Systems | 2 | 2022 | 270 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 17446 | 0.220 |
Why?
|
| Workflow | 2 | 2022 | 847 | 0.190 |
Why?
|
| Growth Differentiation Factors | 1 | 2021 | 98 | 0.190 |
Why?
|
| Ammonia | 1 | 2020 | 239 | 0.170 |
Why?
|
| Biological Specimen Banks | 2 | 2021 | 711 | 0.170 |
Why?
|
| Methyltransferases | 1 | 2022 | 367 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 154 | 0.170 |
Why?
|
| Genitalia | 1 | 2019 | 112 | 0.170 |
Why?
|
| Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 675 | 0.170 |
Why?
|
| Genetic Variation | 4 | 2021 | 6544 | 0.160 |
Why?
|
| Urea | 1 | 2020 | 450 | 0.160 |
Why?
|
| Databases, Genetic | 2 | 2022 | 1783 | 0.150 |
Why?
|
| Neonatal Screening | 2 | 2018 | 591 | 0.150 |
Why?
|
| Age of Onset | 2 | 2020 | 3271 | 0.140 |
Why?
|
| Information Dissemination | 2 | 2015 | 1099 | 0.140 |
Why?
|
| Dystonic Disorders | 1 | 2020 | 329 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.140 |
Why?
|
| Hypogastric Plexus | 1 | 1995 | 10 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 839 | 0.140 |
Why?
|
| Disease | 1 | 2021 | 680 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.130 |
Why?
|
| Ganglia | 1 | 1995 | 89 | 0.130 |
Why?
|
| Smad4 Protein | 1 | 2016 | 163 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 147 | 0.130 |
Why?
|
| Cryptorchidism | 1 | 2016 | 125 | 0.130 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2016 | 144 | 0.130 |
Why?
|
| Eye | 1 | 2019 | 729 | 0.130 |
Why?
|
| Hand Deformities, Congenital | 1 | 2016 | 146 | 0.130 |
Why?
|
| Primary Health Care | 3 | 2017 | 4558 | 0.130 |
Why?
|
| Cadherins | 1 | 2019 | 907 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2019 | 737 | 0.120 |
Why?
|
| Death | 1 | 2019 | 678 | 0.120 |
Why?
|
| Genetic Counseling | 2 | 2018 | 600 | 0.120 |
Why?
|
| Sequence Analysis | 1 | 2015 | 256 | 0.120 |
Why?
|
| Phenotype | 7 | 2023 | 16365 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2017 | 783 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4803 | 0.110 |
Why?
|
| Genetics, Medical | 1 | 2015 | 338 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 1995 | 1263 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2133 | 0.100 |
Why?
|
| Neural Inhibition | 1 | 1995 | 602 | 0.100 |
Why?
|
| Research Report | 1 | 2015 | 355 | 0.100 |
Why?
|
| Truth Disclosure | 1 | 2015 | 436 | 0.100 |
Why?
|
| Axons | 1 | 2019 | 1684 | 0.100 |
Why?
|
| Nicotine | 1 | 1995 | 681 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2015 | 553 | 0.090 |
Why?
|
| Mutation | 4 | 2020 | 29786 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15165 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2019 | 2240 | 0.090 |
Why?
|
| Humans | 35 | 2024 | 744343 | 0.090 |
Why?
|
| Sepsis | 1 | 2024 | 2593 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1622 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 1178 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19905 | 0.080 |
Why?
|
| Research Design | 2 | 2014 | 5987 | 0.080 |
Why?
|
| Mutation, Missense | 3 | 2023 | 2564 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2020 | 231 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2019 | 1901 | 0.080 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.070 |
Why?
|
| Multifactorial Inheritance | 1 | 2014 | 1194 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 2291 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2538 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2020 | 6196 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1363 | 0.070 |
Why?
|
| Cardiomyopathies | 2 | 2014 | 1912 | 0.060 |
Why?
|
| Adenoma | 1 | 2016 | 2174 | 0.060 |
Why?
|
| Female | 17 | 2021 | 380194 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4251 | 0.060 |
Why?
|
| Young Adult | 6 | 2020 | 56430 | 0.060 |
Why?
|
| Disclosure | 2 | 2021 | 736 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.060 |
Why?
|
| Male | 15 | 2021 | 350118 | 0.060 |
Why?
|
| Sarcoma | 1 | 2015 | 1897 | 0.060 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2023 | 50 | 0.060 |
Why?
|
| Receptors, Complement | 1 | 2024 | 264 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
| Heterozygote | 2 | 2020 | 2804 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2529 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4584 | 0.050 |
Why?
|
| Adult | 11 | 2021 | 214055 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 20 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 429 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 11725 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2023 | 246 | 0.050 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 2703 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 313 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 425 | 0.050 |
Why?
|
| Zebrafish | 2 | 2023 | 2994 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.050 |
Why?
|
| Genetic Research | 1 | 2021 | 174 | 0.050 |
Why?
|
| HLA-A Antigens | 1 | 2021 | 231 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12208 | 0.050 |
Why?
|
| Health Care Costs | 3 | 2018 | 3209 | 0.050 |
Why?
|
| Reflex, Abnormal | 1 | 2020 | 84 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4253 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 12261 | 0.040 |
Why?
|
| Child | 7 | 2023 | 77709 | 0.040 |
Why?
|
| HLA-B Antigens | 1 | 2021 | 353 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 213383 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2023 | 1880 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 165 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2020 | 248 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 304 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 399 | 0.040 |
Why?
|
| Laryngeal Diseases | 1 | 2020 | 241 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 77449 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 570 | 0.040 |
Why?
|
| Lung | 1 | 2015 | 9856 | 0.040 |
Why?
|
| Dystonia | 1 | 2020 | 363 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2020 | 41006 | 0.040 |
Why?
|
| Microcephaly | 1 | 2020 | 432 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
| Intention | 1 | 2018 | 341 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1349 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 197 | 0.030 |
Why?
|
| Syndrome | 1 | 2022 | 3251 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.030 |
Why?
|
| Heredity | 1 | 2016 | 154 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 163280 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2019 | 8324 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 995 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 1456 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 1419 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 551 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 328 | 0.030 |
Why?
|
| Spine | 1 | 2021 | 1144 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1386 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 907 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11124 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2020 | 748 | 0.030 |
Why?
|
| Adolescent | 5 | 2020 | 85781 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2022 | 1888 | 0.030 |
Why?
|
| Warfarin | 1 | 2021 | 1496 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2016 | 550 | 0.030 |
Why?
|
| Genome | 1 | 2021 | 1808 | 0.030 |
Why?
|
| Patients | 1 | 2018 | 900 | 0.030 |
Why?
|
| Prognosis | 3 | 2019 | 29063 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 3923 | 0.030 |
Why?
|
| Inservice Training | 1 | 2014 | 392 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 2752 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13102 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 4776 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2437 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 168757 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2016 | 5985 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20822 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 591 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2018 | 25625 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4644 | 0.020 |
Why?
|
| DNA | 1 | 2021 | 7301 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 3520 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4186 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2018 | 23338 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 35136 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6622 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2020 | 4043 | 0.020 |
Why?
|
| Health Behavior | 1 | 2017 | 2636 | 0.020 |
Why?
|
| Health Personnel | 1 | 2018 | 3218 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6895 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
| Decision Making | 1 | 2018 | 3887 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3528 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15076 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 21827 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 5102 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 3022 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6933 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20129 | 0.010 |
Why?
|
| Stroke | 1 | 2005 | 9981 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 63114 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
| Curriculum | 1 | 2014 | 3605 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3843 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 53288 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 12804 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9959 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21746 | 0.010 |
Why?
|
| Neurons | 1 | 1995 | 9338 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57776 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69872 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 39050 | 0.000 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_